[
  {
    "ts": "2025-12-22T14:53:22+00:00",
    "headline": "Baird Reaffirms Buy on Intuitive Surgical (ISRG) After New FDA Clearances",
    "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best healthcare AI stocks to buy now. On December 16, David Rescott from Robert W. Baird reaffirmed a Buy rating on Intuitive Surgical, Inc. (NASDAQ:ISRG) and maintained the $655 price target. Earlier on December 11, Citi’s Joanne Wuensch assigned a Hold rating on the stock. In a […]",
    "url": "https://finance.yahoo.com/news/baird-reaffirms-buy-intuitive-surgical-145322537.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6f38dc65-f5b8-39f4-b5eb-82dd752aa38c",
      "content": {
        "id": "6f38dc65-f5b8-39f4-b5eb-82dd752aa38c",
        "contentType": "STORY",
        "title": "Baird Reaffirms Buy on Intuitive Surgical (ISRG) After New FDA Clearances",
        "description": "",
        "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best healthcare AI stocks to buy now. On December 16, David Rescott from Robert W. Baird reaffirmed a Buy rating on Intuitive Surgical, Inc. (NASDAQ:ISRG) and maintained the $655 price target. Earlier on December 11, Citi’s Joanne Wuensch assigned a Hold rating on the stock. In a […]",
        "pubDate": "2025-12-22T14:53:22Z",
        "displayTime": "2025-12-22T14:53:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/32fdc505192cea2c24da8f4f4ae83c46",
          "originalWidth": 200,
          "originalHeight": 200,
          "caption": "Baird Reaffirms Buy on Intuitive Surgical (ISRG) After New FDA Clearances",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XCjttiYJ7HV7XfaXg_X1Uw--~B/aD0yMDA7dz0yMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/32fdc505192cea2c24da8f4f4ae83c46.cf.webp",
              "width": 200,
              "height": 200,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_eTRgRo8UOjuoBVQSeTSBQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/32fdc505192cea2c24da8f4f4ae83c46.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/baird-reaffirms-buy-intuitive-surgical-145322537.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/baird-reaffirms-buy-intuitive-surgical-145322537.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]